Shifting from Correlation to Causation: Challenges for the Future of Unbiased Molecular Studies in Inflammatory Lung Disease

Stephanie A Christenson¹, Katrina Steiling^{2

3}

Affiliations

¹ 1 Department of Medicine University of California, San Francisco San Francisco, California.
² 2 Department of Medicine Boston University School of Medicine Boston, Massachusetts and.
³ 3 Bioinformatics Program Boston University Boston, Massachusetts.

Comment

Stephanie A Christenson et al. Am J Respir Crit Care Med. 2017.

. 2017 Jan 1;195(1):5-7.

doi: 10.1164/rccm.201608-1751ED.

Stephanie A Christenson¹, Katrina Steiling^{2

3}

¹ 1 Department of Medicine University of California, San Francisco San Francisco, California.
² 2 Department of Medicine Boston University School of Medicine Boston, Massachusetts and.
³ 3 Bioinformatics Program Boston University Boston, Massachusetts.

No abstract available

Comment on

MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Conickx G, Mestdagh P, Avila Cobos F, Verhamme FM, Maes T, Vanaudenaerde BM, Seys LJ, Lahousse L, Kim RY, Hsu AC, Wark PA, Hansbro PM, Joos GF, Vandesompele J, Bracke KR, Brusselle GG. Conickx G, et al. Am J Respir Crit Care Med. 2017 Jan 1;195(1):43-56. doi: 10.1164/rccm.201506-1182OC. Am J Respir Crit Care Med. 2017. PMID: 27409149

1. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, et al. Global Health Epidemiology Reference Group (GHERG) Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5:020415. - PMC - PubMed
1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741–750. - PubMed
1. Bossé Y. Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications. Pharmacogenomics. 2009;10:655–667. - PubMed
1. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. - PubMed
1. Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, Lenburg ME, Spira A, Woodruff PG. Asthma-COPD overlap: clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191:758–766. - PMC - PubMed